# Retinal Blood Flow and Microthrombi in Type 1 Diabetes

> **NCT00406991** · PHASE2 · COMPLETED · sponsor: **Schepens Eye Research Institute** · enrollment: 100 (—)

## Conditions studied

- Diabetes
- Diabetic Retinopathy

## Interventions

- **DRUG:** aspirin
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT00406991
- **Lead sponsor:** Schepens Eye Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 100 (—)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406991, "Retinal Blood Flow and Microthrombi in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00406991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*